Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jan 24;16(3):511.
doi: 10.3390/cancers16030511.

Radiotherapy of Oligometastatic Cancers

Filippo Alongi  1   2 , Simona Gaito  3   4
Affiliations
Editorial

Radiotherapy of Oligometastatic Cancers

Filippo Alongi et al. Cancers (Basel). .

Abstract

The enhanced multidisciplinary treatment approach and the widespread use of advanced imaging techniques have led to an improvement in survival rates, inevitably associated with an increase in the number of oligometastatic diagnoses in cancer patients [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Hellman S., Weichselbaum R.R. Oligometastases. J. Clin. Oncol. 1995;13:1–8. doi: 10.1200/JCO.1995.13.1.8. - DOI - PubMed
    1. Barry A.S., Helou J., Bezjak A., Wong R., Dawson L.A., Ringash J., Fazelzad R., Liu Z., Olson R., Palma D., et al. Health related quality of life outcomes following stereotactic body radiotherapy in patients with oligo-metastatic disease: A systematic review and individual patient data meta-analysis. Radiother. Oncol. 2022;173:163–169. doi: 10.1016/j.radonc.2022.05.033. - DOI - PubMed
    1. Palma D.A., Olson R., Harrow S., Gaede S., Louie A.V., Haasbeek C., Mulroy L., Lock M., Rodrigues G.B., Yaremko B.P., et al. Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial. J. Clin. Oncol. 2020;38:2830–2838. doi: 10.1200/JCO.20.00818. - DOI - PMC - PubMed
    1. Vorbach S.M., Mangesius J., Dejaco D., Seppi T., Santer M., Zur Nedden S., Sarcletti M.P., Pointner M.J., Hart T.J., Riechelmann H., et al. Survival, Treatment Outcome, and Safety of Multiple and Repeated Courses of Stereotactic Body Radiotherapy for Pulmonary Oligometastases of Head and Neck Squamous Cell Carcinoma. Cancers. 2023;15:5253. doi: 10.3390/cancers15215253. - DOI - PMC - PubMed
    1. Marvaso G., Mastroleo F., Corrao G., Zaffaroni M., Vincini M.G., Borghetti P., Cuccia F., Federico M., Montesi G., Pontoriero A., et al. A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group. Cancers. 2023;15:3902. doi: 10.3390/cancers15153902. - DOI - PMC - PubMed

Publication types

LinkOut - more resources